Do analysts recommend BLCO or UFPT?

Bausch + Lomb presently has a consensus price target of $20.75, suggesting a potential upside of 3.80%. Given Bausch + Lomb's stronger consensus rating and higher probable upside, analysts plainly believe Bausch + Lomb is more favorable than UFP Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bausch + Lomb 1 Sell rating(s) 7 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.43 UFP Technologies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media favor BLCO or UFPT?

In the previous week, Bausch + Lomb had 34 more articles in the media than UFP Technologies. MarketBeat recorded 37 mentions for Bausch + Lomb and 3 mentions for UFP Technologies. Bausch + Lomb's average media sentiment score of 0.61 beat UFP Technologies' score of 0.60 indicating that Bausch + Lomb is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bausch + Lomb 8 Very Positive mention(s) 9 Positive mention(s) 16 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive UFP Technologies 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer MMSI or UFPT?

Merit Medical Systems currently has a consensus target price of $105.55, suggesting a potential upside of 22.39%. Given Merit Medical Systems' stronger consensus rating and higher possible upside, equities analysts clearly believe Merit Medical Systems is more favorable than UFP Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Merit Medical Systems 0 Sell rating(s) 5 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.62 UFP Technologies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media favor MMSI or UFPT?

In the previous week, Merit Medical Systems had 27 more articles in the media than UFP Technologies. MarketBeat recorded 30 mentions for Merit Medical Systems and 3 mentions for UFP Technologies. Merit Medical Systems' average media sentiment score of 1.06 beat UFP Technologies' score of 0.60 indicating that Merit Medical Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Merit Medical Systems 14 Very Positive mention(s) 3 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive UFP Technologies 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer UFPT or ICUI?

ICU Medical has a consensus price target of $192.80, indicating a potential upside of 17.72%. Given ICU Medical's stronger consensus rating and higher probable upside, analysts clearly believe ICU Medical is more favorable than UFP Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score UFP Technologies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 ICU Medical 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 2 Strong Buy rating(s) 2.89

Does the media prefer UFPT or ICUI?

In the previous week, ICU Medical had 2 more articles in the media than UFP Technologies. MarketBeat recorded 5 mentions for ICU Medical and 3 mentions for UFP Technologies. ICU Medical's average media sentiment score of 0.86 beat UFP Technologies' score of 0.60 indicating that ICU Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment UFP Technologies 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive ICU Medical 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate UFPT or NVST?

Envista has a consensus target price of $28.86, suggesting a potential upside of 22.90%. Given Envista's stronger consensus rating and higher probable upside, analysts clearly believe Envista is more favorable than UFP Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score UFP Technologies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Envista 0 Sell rating(s) 11 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.35

Does the media refer more to UFPT or NVST?

In the previous week, UFP Technologies and UFP Technologies both had 3 articles in the media. UFP Technologies' average media sentiment score of 0.60 beat Envista's score of 0.33 indicating that UFP Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment UFP Technologies 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Envista 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate NEOG or UFPT?

Neogen presently has a consensus price target of $12.67, indicating a potential upside of 7.16%. Given Neogen's stronger consensus rating and higher possible upside, equities research analysts clearly believe Neogen is more favorable than UFP Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Neogen 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 UFP Technologies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Is NEOG or UFPT more profitable?

UFP Technologies has a net margin of 11.45% compared to Neogen's net margin of -6.35%. UFP Technologies' return on equity of 18.42% beat Neogen's return on equity. Company Net Margins Return on Equity Return on Assets Neogen -6.35% 3.29% 2.06% UFP Technologies 11.45% 18.42% 11.96%

Does the media favor NEOG or UFPT?

In the previous week, Neogen had 13 more articles in the media than UFP Technologies. MarketBeat recorded 16 mentions for Neogen and 3 mentions for UFP Technologies. Neogen's average media sentiment score of 0.83 beat UFP Technologies' score of 0.60 indicating that Neogen is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Neogen 2 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive UFP Technologies 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

UFP Technologies (UFPT) Competitors

$284.50 -8.80 (-3.00%)

Closing price 10/30/2026 04:00 PM Eastern

Extended Trading

$283.90 -0.61 (-0.21%)

As of 10/30/2026 07:56 PM Eastern

Compare

UFPT vs. BLCO, MMSI, ICUI, NVST, and NEOG

Should you buy UFP Technologies stock or one of its competitors? UFP Technologies's main competitors and comparable companies include Bausch + Lomb (BLCO), Merit Medical Systems (MMSI), ICU Medical (ICUI), Envista (NVST), and Neogen (NEOG). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does UFP Technologies compare to Bausch + Lomb?

Bausch + Lomb (NYSE:BLCO) and UFP Technologies (NASDAQ:UFPT) are both mid-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, media sentiment, risk, institutional ownership, valuation, earnings and analyst recommendations.

11.1% of Bausch + Lomb shares are owned by institutional investors. Comparatively, 87.3% of UFP Technologies shares are owned by institutional investors. 1.5% of Bausch + Lomb shares are owned by company insiders. Comparatively, 4.6% of UFP Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

UFP Technologies has a net margin of 11.45% compared to Bausch + Lomb's net margin of -2.05%. UFP Technologies' return on equity of 18.42% beat Bausch + Lomb's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bausch + Lomb	-2.05%	5.01%	2.34%
UFP Technologies	11.45%	18.42%	11.96%

Bausch + Lomb has a beta of 0.56, meaning that its stock price is 44% less volatile than the broader market. Comparatively, UFP Technologies has a beta of 1.04, meaning that its stock price is 4% more volatile than the broader market.

In the previous week, Bausch + Lomb had 34 more articles in the media than UFP Technologies. MarketBeat recorded 37 mentions for Bausch + Lomb and 3 mentions for UFP Technologies. Bausch + Lomb's average media sentiment score of 0.61 beat UFP Technologies' score of 0.60 indicating that Bausch + Lomb is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bausch + Lomb	8 Very Positive mention(s)	9 Positive mention(s)	16 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
UFP Technologies	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

UFP Technologies has lower revenue, but higher earnings than Bausch + Lomb. Bausch + Lomb is trading at a lower price-to-earnings ratio than UFP Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bausch + Lomb	$5.10B	1.40	-$360M	-$0.31	N/A
UFP Technologies	$602.80M	3.66	$68.31M	$9.28	30.66

Bausch + Lomb presently has a consensus price target of $20.75, suggesting a potential upside of 3.80%. Given Bausch + Lomb's stronger consensus rating and higher probable upside, analysts plainly believe Bausch + Lomb is more favorable than UFP Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bausch + Lomb	1 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.43
UFP Technologies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

UFP Technologies beats Bausch + Lomb on 10 of the 17 factors compared between the two stocks.

How does UFP Technologies compare to Merit Medical Systems?

Merit Medical Systems (NASDAQ:MMSI) and UFP Technologies (NASDAQ:UFPT) are both mid-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, media sentiment, dividends and analyst recommendations.

UFP Technologies has a net margin of 11.45% compared to Merit Medical Systems' net margin of 9.94%. UFP Technologies' return on equity of 18.42% beat Merit Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Merit Medical Systems	9.94%	14.37%	8.50%
UFP Technologies	11.45%	18.42%	11.96%

Merit Medical Systems has a beta of 0.51, meaning that its share price is 49% less volatile than the broader market. Comparatively, UFP Technologies has a beta of 1.04, meaning that its share price is 4% more volatile than the broader market.

Merit Medical Systems currently has a consensus target price of $105.55, suggesting a potential upside of 22.39%. Given Merit Medical Systems' stronger consensus rating and higher possible upside, equities analysts clearly believe Merit Medical Systems is more favorable than UFP Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Merit Medical Systems	0 Sell rating(s)	5 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.62
UFP Technologies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

99.7% of Merit Medical Systems shares are owned by institutional investors. Comparatively, 87.3% of UFP Technologies shares are owned by institutional investors. 0.7% of Merit Medical Systems shares are owned by insiders. Comparatively, 4.6% of UFP Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Merit Medical Systems has higher revenue and earnings than UFP Technologies. UFP Technologies is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Merit Medical Systems	$1.52B	3.40	$128.49M	$2.42	35.64
UFP Technologies	$602.80M	3.66	$68.31M	$9.28	30.66

In the previous week, Merit Medical Systems had 27 more articles in the media than UFP Technologies. MarketBeat recorded 30 mentions for Merit Medical Systems and 3 mentions for UFP Technologies. Merit Medical Systems' average media sentiment score of 1.06 beat UFP Technologies' score of 0.60 indicating that Merit Medical Systems is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Merit Medical Systems	14 Very Positive mention(s)	3 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
UFP Technologies	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Merit Medical Systems beats UFP Technologies on 9 of the 16 factors compared between the two stocks.

How does UFP Technologies compare to ICU Medical?

UFP Technologies (NASDAQ:UFPT) and ICU Medical (NASDAQ:ICUI) are both mid-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

UFP Technologies has a net margin of 11.45% compared to ICU Medical's net margin of 1.39%. UFP Technologies' return on equity of 18.42% beat ICU Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
UFP Technologies	11.45%	18.42%	11.96%
ICU Medical	1.39%	7.91%	4.17%

In the previous week, ICU Medical had 2 more articles in the media than UFP Technologies. MarketBeat recorded 5 mentions for ICU Medical and 3 mentions for UFP Technologies. ICU Medical's average media sentiment score of 0.86 beat UFP Technologies' score of 0.60 indicating that ICU Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
UFP Technologies	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
ICU Medical	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

ICU Medical has a consensus price target of $192.80, indicating a potential upside of 17.72%. Given ICU Medical's stronger consensus rating and higher probable upside, analysts clearly believe ICU Medical is more favorable than UFP Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
UFP Technologies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
ICU Medical	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	2 Strong Buy rating(s)	2.89

UFP Technologies has a beta of 1.04, suggesting that its stock price is 4% more volatile than the broader market. Comparatively, ICU Medical has a beta of 0.86, suggesting that its stock price is 14% less volatile than the broader market.

UFP Technologies has higher earnings, but lower revenue than ICU Medical. UFP Technologies is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
UFP Technologies	$602.80M	3.66	$68.31M	$9.28	30.66
ICU Medical	$2.23B	1.83	$730K	$1.18	138.80

87.3% of UFP Technologies shares are owned by institutional investors. Comparatively, 96.1% of ICU Medical shares are owned by institutional investors. 4.6% of UFP Technologies shares are owned by insiders. Comparatively, 2.1% of ICU Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

ICU Medical beats UFP Technologies on 9 of the 17 factors compared between the two stocks.

How does UFP Technologies compare to Envista?

UFP Technologies (NASDAQ:UFPT) and Envista (NYSE:NVST) are both mid-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, media sentiment, institutional ownership, risk, valuation, dividends and profitability.

UFP Technologies has a net margin of 11.45% compared to Envista's net margin of 3.33%. UFP Technologies' return on equity of 18.42% beat Envista's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
UFP Technologies	11.45%	18.42%	11.96%
Envista	3.33%	7.88%	4.33%

Envista has a consensus target price of $28.86, suggesting a potential upside of 22.90%. Given Envista's stronger consensus rating and higher probable upside, analysts clearly believe Envista is more favorable than UFP Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
UFP Technologies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Envista	0 Sell rating(s)	11 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.35

87.3% of UFP Technologies shares are held by institutional investors. 4.6% of UFP Technologies shares are held by company insiders. Comparatively, 1.0% of Envista shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, UFP Technologies and UFP Technologies both had 3 articles in the media. UFP Technologies' average media sentiment score of 0.60 beat Envista's score of 0.33 indicating that UFP Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
UFP Technologies	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Envista	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

UFP Technologies has higher earnings, but lower revenue than Envista. UFP Technologies is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
UFP Technologies	$602.80M	3.66	$68.31M	$9.28	30.66
Envista	$2.72B	1.39	$47M	$0.58	40.48

UFP Technologies has a beta of 1.04, meaning that its share price is 4% more volatile than the broader market. Comparatively, Envista has a beta of 0.89, meaning that its share price is 11% less volatile than the broader market.

Summary

UFP Technologies beats Envista on 10 of the 15 factors compared between the two stocks.

How does UFP Technologies compare to Neogen?

Neogen (NASDAQ:NEOG) and UFP Technologies (NASDAQ:UFPT) are both mid-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, valuation, media sentiment, analyst recommendations, dividends, risk and institutional ownership.

In the previous week, Neogen had 13 more articles in the media than UFP Technologies. MarketBeat recorded 16 mentions for Neogen and 3 mentions for UFP Technologies. Neogen's average media sentiment score of 0.83 beat UFP Technologies' score of 0.60 indicating that Neogen is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Neogen	2 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
UFP Technologies	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Neogen presently has a consensus price target of $12.67, indicating a potential upside of 7.16%. Given Neogen's stronger consensus rating and higher possible upside, equities research analysts clearly believe Neogen is more favorable than UFP Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Neogen	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
UFP Technologies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

96.7% of Neogen shares are held by institutional investors. Comparatively, 87.3% of UFP Technologies shares are held by institutional investors. 0.5% of Neogen shares are held by company insiders. Comparatively, 4.6% of UFP Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Neogen has a beta of 1.79, indicating that its share price is 79% more volatile than the broader market. Comparatively, UFP Technologies has a beta of 1.04, indicating that its share price is 4% more volatile than the broader market.

UFP Technologies has a net margin of 11.45% compared to Neogen's net margin of -6.35%. UFP Technologies' return on equity of 18.42% beat Neogen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Neogen	-6.35%	3.29%	2.06%
UFP Technologies	11.45%	18.42%	11.96%

UFP Technologies has lower revenue, but higher earnings than Neogen. Neogen is trading at a lower price-to-earnings ratio than UFP Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Neogen	$870.40M	2.96	-$7.90M	-$0.25	N/A
UFP Technologies	$602.80M	3.66	$68.31M	$9.28	30.66

Summary

Neogen and UFP Technologies tied by winning 8 of the 16 factors compared between the two stocks.

Get UFP Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UFPT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

UFPT vs. The Competition

Export

Metric	UFP Technologies	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$2.20B	$5.85B	$7.83B	$12.21B
Dividend Yield	N/A	1.72%	2.48%	4.46%
P/E Ratio	30.66	41.40	35.75	32.49
Price / Sales	3.66	5.18	8.85	6.01
Price / Cash	23.03	22.65	20.87	22.76
Price / Book	5.18	5.12	4.90	4.08
Net Income	$68.31M	$145.16M	$3.50B	$381.88M
7 Day Performance	-3.81%	0.14%	0.16%	-0.70%
1 Month Performance	-3.56%	-2.64%	-5.14%	-6.62%
1 Year Performance	47.68%	1.47%	-0.21%	-6.92%

UFP Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
UFPT UFP Technologies	1.5822 of 5 stars	$284.50 -3.0%	N/A	+47.7%	$2.20B	$602.80M	30.66	5,349	Upcoming Earnings
BLCO Bausch + Lomb	4.0638 of 5 stars	$17.56 +0.5%	$19.46 +10.8%	+33.8%	$6.24B	$5.10B	N/A	13,000	Trending News Earnings Report Analyst Forecast
MMSI Merit Medical Systems	3.4837 of 5 stars	$94.20 +1.0%	$100.00 +6.2%	-1.5%	$5.57B	$1.52B	25.42	7,500	Trending News Earnings Report Analyst Forecast
ICUI ICU Medical	3.2813 of 5 stars	$165.96 -0.4%	$192.80 +16.2%	+36.4%	$4.16B	$2.23B	140.64	13,000	News Coverage Upcoming Earnings
NVST Envista	3.3189 of 5 stars	$23.67 +0.3%	$28.86 +21.9%	+15.5%	$3.79B	$2.72B	40.80	12,000	Upcoming Earnings

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:UFPT) was last updated on 11/1/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

UFP Technologies (UFPT) Competitors

UFPT vs. BLCO, MMSI, ICUI, NVST, and NEOG

How does UFP Technologies compare to Bausch + Lomb?

Summary

How does UFP Technologies compare to Merit Medical Systems?

Summary

How does UFP Technologies compare to ICU Medical?

Summary

How does UFP Technologies compare to Envista?

Summary

How does UFP Technologies compare to Neogen?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

UFPT vs. The Competition

UFP Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

UFP Technologies (UFPT) Competitors

UFPT vs. BLCO, MMSI, ICUI, NVST, and NEOG

How does UFP Technologies compare to Bausch + Lomb?

Do institutionals and insiders hold more shares of BLCO or UFPT?

Is BLCO or UFPT more profitable?

Which has more volatility & risk, BLCO or UFPT?

Does the media favor BLCO or UFPT?

Which has preferable earnings & valuation, BLCO or UFPT?

Do analysts recommend BLCO or UFPT?

Summary

How does UFP Technologies compare to Merit Medical Systems?

Is MMSI or UFPT more profitable?

Which has more volatility and risk, MMSI or UFPT?

Do analysts prefer MMSI or UFPT?

Do insiders and institutionals hold more shares of MMSI or UFPT?

Which has stronger valuation & earnings, MMSI or UFPT?

Does the media favor MMSI or UFPT?

Summary

How does UFP Technologies compare to ICU Medical?

Is UFPT or ICUI more profitable?

Does the media prefer UFPT or ICUI?

Do analysts prefer UFPT or ICUI?

Which has more risk & volatility, UFPT or ICUI?

Which has preferable valuation and earnings, UFPT or ICUI?

Do institutionals & insiders believe in UFPT or ICUI?

Summary

How does UFP Technologies compare to Envista?

Is UFPT or NVST more profitable?

Do analysts rate UFPT or NVST?

Do institutionals and insiders believe in UFPT or NVST?

Does the media refer more to UFPT or NVST?

Which has preferable earnings and valuation, UFPT or NVST?

Which has more volatility and risk, UFPT or NVST?

Summary

How does UFP Technologies compare to Neogen?

Does the media favor NEOG or UFPT?

Do analysts rate NEOG or UFPT?

Do insiders and institutionals have more ownership in NEOG or UFPT?

Which has more risk & volatility, NEOG or UFPT?

Is NEOG or UFPT more profitable?

Which has higher valuation and earnings, NEOG or UFPT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

UFPT vs. The Competition

UFP Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools